Literature DB >> 19357172

The orthopoxvirus 68-kilodalton ankyrin-like protein is essential for DNA replication and complete gene expression of modified vaccinia virus Ankara in nonpermissive human and murine cells.

Karin M Sperling1, Astrid Schwantes, Caroline Staib, Barbara S Schnierle, Gerd Sutter.   

Abstract

Modified vaccinia virus Ankara (MVA) is a highly attenuated and replication-deficient vaccinia virus (VACV) that is being evaluated as replacement smallpox vaccine and candidate viral vector. MVA lacks many genes associated with virulence and/or regulation of virus tropism. The 68-kDa ankyrin-like protein (68k-ank) is the only ankyrin repeat-containing protein that is encoded by the MVA genome and is highly conserved throughout the Orthopoxvirus genus. We showed previously that 68k-ank is composed of ankyrin repeats and an F-box-like domain and forms an SCF ubiquitin ligase complex together with the cellular proteins Skp1a and Cullin-1. We now report that 68k-ank (MVA open reading frame 186R) is an essential factor for completion of the MVA intracellular life cycle in nonpermissive human and murine cells. Infection of mouse NIH 3T3 and human HaCaT cells with MVA with a deletion of the 68k-ank gene (MVA-Delta68k-ank) was characterized by an extensive reduction of viral intermediate RNA and protein, as well as late transcripts and drastically impaired late protein synthesis. Furthermore, infections with MVA-Delta68k-ank failed to induce the host protein shutoff that is characteristic of VACV infections. Although we demonstrated that proteasome function in general is essential for the completion of the MVA molecular life cycle, we found that a mutant 68k-ank protein with a deletion of the F-box-like domain was able to fully complement the deficiency of MVA-Delta68k-ank to express all classes of viral genes. Thus, our data demonstrate that the 68k-ank protein contains another critical domain that may function independently of SCF ubiquitin ligase complex formation, suggesting multiple activities of this interesting regulatory protein.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19357172      PMCID: PMC2687370          DOI: 10.1128/JVI.01628-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

Review 1.  Immunology 102 at poxvirus U: avoiding apoptosis.

Authors:  J L Shisler; B Moss
Journal:  Semin Immunol       Date:  2001-02       Impact factor: 11.130

2.  Improved host range selection for recombinant modified vaccinia virus Ankara.

Authors:  Caroline Staib; Marianne Löwel; Volker Erfle; Gerd Sutter
Journal:  Biotechniques       Date:  2003-04       Impact factor: 1.993

Review 3.  Ratchets and clocks: the cell cycle, ubiquitylation and protein turnover.

Authors:  Steven I Reed
Journal:  Nat Rev Mol Cell Biol       Date:  2003-11       Impact factor: 94.444

Review 4.  Poxviruses and immune evasion.

Authors:  Bruce T Seet; J B Johnston; Craig R Brunetti; John W Barrett; Helen Everett; Cheryl Cameron; Joanna Sypula; Steven H Nazarian; Alexandra Lucas; Grant McFadden
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

Review 5.  The ankyrin repeat as molecular architecture for protein recognition.

Authors:  Leila K Mosavi; Tobin J Cammett; Daniel C Desrosiers; Zheng-Yu Peng
Journal:  Protein Sci       Date:  2004-06       Impact factor: 6.725

Review 6.  The SCF ubiquitin ligase: insights into a molecular machine.

Authors:  Timothy Cardozo; Michele Pagano
Journal:  Nat Rev Mol Cell Biol       Date:  2004-09       Impact factor: 94.444

7.  Inhibition of the ubiquitin-proteasome system prevents vaccinia virus DNA replication and expression of intermediate and late genes.

Authors:  P S Satheshkumar; Luis C Anton; Patrick Sanz; Bernard Moss
Journal:  J Virol       Date:  2009-01-07       Impact factor: 5.103

8.  Sequential protein synthesis following vaccinia virus infection.

Authors:  B Moss; N P Salzman
Journal:  J Virol       Date:  1968-10       Impact factor: 5.103

9.  Poxvirus host range protein CP77 contains an F-box-like domain that is necessary to suppress NF-kappaB activation by tumor necrosis factor alpha but is independent of its host range function.

Authors:  Shu-Jung Chang; Jye-Chian Hsiao; Stephanie Sonnberg; Cheng-Ting Chiang; Min-Hsiang Yang; Der-Lii Tzou; Andrew A Mercer; Wen Chang
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

10.  Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.

Authors:  Simone Hornemann; Olof Harlin; Caroline Staib; Sigrid Kisling; Volker Erfle; Bernd Kaspers; Georg Häcker; Gerd Sutter
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

View more
  10 in total

1.  Structure function studies of vaccinia virus host range protein k1 reveal a novel functional surface for ankyrin repeat proteins.

Authors:  Yongchao Li; Xiangzhi Meng; Yan Xiang; Junpeng Deng
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

2.  MNF, an ankyrin repeat protein of myxoma virus, is part of a native cellular SCF complex during viral infection.

Authors:  Sophie Blanié; Jacqueline Gelfi; Stéphane Bertagnoli; Christelle Camus-Bouclainville
Journal:  Virol J       Date:  2010-03-08       Impact factor: 4.099

3.  Identification of Poxvirus Genome Uncoating and DNA Replication Factors with Mutually Redundant Roles.

Authors:  Baoming Liu; Debasis Panda; Jorge D Mendez-Rios; Sundar Ganesan; Linda S Wyatt; Bernard Moss
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

4.  Orthopoxvirus genes that mediate disease virulence and host tropism.

Authors:  Sergei N Shchelkunov
Journal:  Adv Virol       Date:  2012-07-30

Review 5.  Interaction of orthopoxviruses with the cellular ubiquitin-ligase system.

Authors:  Sergei N Shchelkunov
Journal:  Virus Genes       Date:  2010-08-12       Impact factor: 2.198

Review 6.  Poxviral ankyrin proteins.

Authors:  Michael H Herbert; Christopher J Squire; Andrew A Mercer
Journal:  Viruses       Date:  2015-02-16       Impact factor: 5.048

7.  The Virology of Taterapox Virus In Vitro.

Authors:  Scott Parker; Leonardo Camilo de Oliveira; Elliot J Lefkowitz; Robert Curtis Hendrickson; Cláudio A Bonjardim; William S M Wold; Hollyce Hartzler; Ryan Crump; Robert Mark Buller
Journal:  Viruses       Date:  2018-08-29       Impact factor: 5.048

Review 8.  Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development.

Authors:  A Volz; G Sutter
Journal:  Adv Virus Res       Date:  2016-08-01       Impact factor: 9.937

Review 9.  Poxviral ANKR/F-box Proteins: Substrate Adapters for Ubiquitylation and More.

Authors:  Robert J Ingham; Farynna Loubich Facundo; Jianing Dong
Journal:  Pathogens       Date:  2022-08-03

10.  Novel Class of Viral Ankyrin Proteins Targeting the Host E3 Ubiquitin Ligase Cullin-2.

Authors:  Valerie Odon; Iliana Georgana; Joe Holley; Jordi Morata; Carlos Maluquer de Motes
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.